Henry Schein (HSIC) Expected to Announce Quarterly Earnings on Tuesday

Henry Schein (NASDAQ:HSICGet Free Report) is expected to post its quarterly earnings results before the market opens on Tuesday, February 25th. Analysts expect Henry Schein to post earnings of $1.23 per share and revenue of $3.25 billion for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Henry Schein Price Performance

HSIC stock opened at $77.24 on Monday. The stock has a market cap of $9.63 billion, a PE ratio of 31.79, a P/E/G ratio of 2.13 and a beta of 0.91. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein has a 12 month low of $63.67 and a 12 month high of $82.63. The company has a 50-day moving average price of $74.14 and a 200 day moving average price of $72.31.

Analyst Upgrades and Downgrades

HSIC has been the subject of several recent analyst reports. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. Barrington Research upped their price target on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research note on Thursday, January 30th. Mizuho assumed coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective on the stock. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Jefferies Financial Group increased their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Eight research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein presently has a consensus rating of “Moderate Buy” and an average price target of $80.09.

View Our Latest Stock Analysis on HSIC

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Earnings History for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.